Literature DB >> 24771249

Glioblastoma at progression: therapy of a challenging problem addressed candidly with evidence-based techniques.

Jeffrey J Olson1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24771249     DOI： 10.1007/s11060-014-1431-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  4 in total

Review 1.  Critical evaluation of oncology clinical practice guidelines.

Authors:  Bradley N Reames; Robert W Krell; Sarah N Ponto; Sandra L Wong
Journal:  J Clin Oncol       Date:  2013-06-10       Impact factor: 44.544

2.  Guidelines for guidelines: measuring trustworthiness.

Authors:  David F Ransohoff; Harold C Sox
Journal:  J Clin Oncol       Date:  2013-06-10       Impact factor: 44.544

3.  Guidelines for the treatment of newly diagnosed glioblastoma: introduction.

Authors:  Jeffrey J Olson; Timothy Ryken
Journal:  J Neurooncol       Date:  2008-05-23       Impact factor: 4.130

4.  Evidence-linked, clinical practice guidelines-getting serious; getting professional.

Authors:  Mark E Linskey; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2010-01       Impact factor: 4.130
  4 in total
  2 in total

Review 1.  Polymeric drug delivery for the treatment of glioblastoma.

Authors:  Scott D Wait; Roshan S Prabhu; Stuart H Burri; Tyler G Atkins; Anthony L Asher
Journal:  Neuro Oncol       Date:  2015-03       Impact factor: 12.300

2.  Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes.

Authors:  Jolanta Janiszewska; Inmaculada Posadas; Pablo Játiva; Marta Bugaj-Zarebska; Zofia Urbanczyk-Lipkowska; Valentín Ceña
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.